Science Daily -
20 May 2016 20:06
A research team has prepared a systematic review that explores the efficacy, safety, and adherence to fixed-dose combinations (FDCs) of drugs versus single-drug formulations to treat people who are newly diagnosed with tuberculosis (TB).
Share this Article